Addition of Raltegravir to Established Antiretroviral Suppressive Therapy
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2010 by University of Miami.
Recruitment status was Not yet recruiting
Recruitment status was Not yet recruiting
Sponsor:
University of Miami
Collaborator:
Merck
Information provided by:
University of Miami
ClinicalTrials.gov Identifier:
NCT01245101
First received: November 19, 2010
Last updated: NA
Last verified: November 2010
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | June 2012 |
| Estimated Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |